Clinical Trial Update: Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of fasinumab vs placebo and NSAIDs for adults with knee or hip osteoarthritis; trial completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Fasinumab (fasinumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 3 | Status: COMPLETED | Results posted: 2023-02-24